nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—colon cancer	0.672	1	CbGaD
Lomitapide—ABCB1—Irinotecan—colon cancer	0.0396	0.284	CbGbCtD
Lomitapide—ABCB1—Vincristine—colon cancer	0.0346	0.248	CbGbCtD
Lomitapide—CYP3A4—Irinotecan—colon cancer	0.0237	0.17	CbGbCtD
Lomitapide—ABCB1—Methotrexate—colon cancer	0.021	0.15	CbGbCtD
Lomitapide—CYP3A4—Vincristine—colon cancer	0.0207	0.149	CbGbCtD
Lomitapide—MTTP—blood vessel—colon cancer	0.0195	0.31	CbGeAlD
Lomitapide—MTTP—embryo—colon cancer	0.0116	0.185	CbGeAlD
Lomitapide—MTTP—renal system—colon cancer	0.00881	0.14	CbGeAlD
Lomitapide—MTTP—digestive system—colon cancer	0.00723	0.115	CbGeAlD
Lomitapide—MTTP—liver—colon cancer	0.00539	0.0856	CbGeAlD
Lomitapide—Frequent bowel movements—Irinotecan—colon cancer	0.00518	0.0423	CcSEcCtD
Lomitapide—Antrafenine—PTGS2—colon cancer	0.00274	0.751	CrCbGaD
Lomitapide—Hepatic steatosis—Capecitabine—colon cancer	0.0027	0.0221	CcSEcCtD
Lomitapide—Abdominal pain lower—Capecitabine—colon cancer	0.00257	0.021	CcSEcCtD
Lomitapide—Blood potassium decreased—Capecitabine—colon cancer	0.00215	0.0176	CcSEcCtD
Lomitapide—Prothrombin level increased—Capecitabine—colon cancer	0.00199	0.0163	CcSEcCtD
Lomitapide—Reaction gastrointestinal—Methotrexate—colon cancer	0.00182	0.0149	CcSEcCtD
Lomitapide—Proctalgia—Capecitabine—colon cancer	0.00174	0.0142	CcSEcCtD
Lomitapide—ABCB1—blood vessel—colon cancer	0.00172	0.0274	CbGeAlD
Lomitapide—Hepatomegaly—Irinotecan—colon cancer	0.00172	0.0141	CcSEcCtD
Lomitapide—Joint swelling—Capecitabine—colon cancer	0.00166	0.0136	CcSEcCtD
Lomitapide—Blister—Fluorouracil—colon cancer	0.00162	0.0133	CcSEcCtD
Lomitapide—Drug interaction—Vincristine—colon cancer	0.00135	0.011	CcSEcCtD
Lomitapide—Blood bilirubin increased—Irinotecan—colon cancer	0.00129	0.0105	CcSEcCtD
Lomitapide—Gait disturbance—Vincristine—colon cancer	0.00128	0.0105	CcSEcCtD
Lomitapide—Gait disturbance—Irinotecan—colon cancer	0.00125	0.0102	CcSEcCtD
Lomitapide—Pharyngolaryngeal pain—Capecitabine—colon cancer	0.00121	0.00989	CcSEcCtD
Lomitapide—Laryngeal pain—Capecitabine—colon cancer	0.0012	0.00979	CcSEcCtD
Lomitapide—Haematemesis—Capecitabine—colon cancer	0.00117	0.00961	CcSEcCtD
Lomitapide—Hepatomegaly—Capecitabine—colon cancer	0.00115	0.00943	CcSEcCtD
Lomitapide—Blister—Capecitabine—colon cancer	0.00113	0.00926	CcSEcCtD
Lomitapide—CYP3A4—renal system—colon cancer	0.0011	0.0175	CbGeAlD
Lomitapide—Rash erythematous—Capecitabine—colon cancer	0.00107	0.00872	CcSEcCtD
Lomitapide—Hepatotoxicity—Capecitabine—colon cancer	0.00106	0.00864	CcSEcCtD
Lomitapide—ABCB1—embryo—colon cancer	0.00103	0.0163	CbGeAlD
Lomitapide—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00102	0.00832	CcSEcCtD
Lomitapide—Pain in extremity—Vincristine—colon cancer	0.000909	0.00743	CcSEcCtD
Lomitapide—Fexofenadine—ABCB1—colon cancer	0.000909	0.249	CrCbGaD
Lomitapide—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.000904	0.00739	CcSEcCtD
Lomitapide—CYP3A4—digestive system—colon cancer	0.000901	0.0143	CbGeAlD
Lomitapide—Dermatitis bullous—Fluorouracil—colon cancer	0.000887	0.00725	CcSEcCtD
Lomitapide—Haematemesis—Methotrexate—colon cancer	0.000875	0.00715	CcSEcCtD
Lomitapide—Blood bilirubin increased—Capecitabine—colon cancer	0.000863	0.00706	CcSEcCtD
Lomitapide—Dehydration—Vincristine—colon cancer	0.000845	0.00691	CcSEcCtD
Lomitapide—ABCB1—epithelium—colon cancer	0.000839	0.0133	CbGeAlD
Lomitapide—Gait disturbance—Capecitabine—colon cancer	0.000836	0.00684	CcSEcCtD
Lomitapide—Dehydration—Irinotecan—colon cancer	0.000823	0.00673	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000819	0.00669	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000797	0.00652	CcSEcCtD
Lomitapide—Hepatotoxicity—Methotrexate—colon cancer	0.000787	0.00643	CcSEcCtD
Lomitapide—ABCB1—renal system—colon cancer	0.000778	0.0124	CbGeAlD
Lomitapide—Dry skin—Fluorouracil—colon cancer	0.000777	0.00635	CcSEcCtD
Lomitapide—Abdominal distension—Irinotecan—colon cancer	0.00077	0.0063	CcSEcCtD
Lomitapide—Nasopharyngitis—Fluorouracil—colon cancer	0.000758	0.0062	CcSEcCtD
Lomitapide—Angina pectoris—Irinotecan—colon cancer	0.000745	0.00609	CcSEcCtD
Lomitapide—Ecchymosis—Capecitabine—colon cancer	0.000738	0.00603	CcSEcCtD
Lomitapide—Angina pectoris—Fluorouracil—colon cancer	0.000714	0.00584	CcSEcCtD
Lomitapide—Weight decreased—Vincristine—colon cancer	0.000711	0.00581	CcSEcCtD
Lomitapide—Weight decreased—Irinotecan—colon cancer	0.000692	0.00566	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000681	0.00557	CcSEcCtD
Lomitapide—CYP3A4—liver—colon cancer	0.000672	0.0107	CbGeAlD
Lomitapide—Gastroenteritis—Capecitabine—colon cancer	0.000669	0.00547	CcSEcCtD
Lomitapide—Infestation NOS—Fluorouracil—colon cancer	0.000653	0.00534	CcSEcCtD
Lomitapide—Infestation—Fluorouracil—colon cancer	0.000653	0.00534	CcSEcCtD
Lomitapide—ABCB1—lymphoid tissue—colon cancer	0.000646	0.0103	CbGeAlD
Lomitapide—Hepatic enzyme increased—Methotrexate—colon cancer	0.000642	0.00525	CcSEcCtD
Lomitapide—ABCB1—digestive system—colon cancer	0.000638	0.0101	CbGeAlD
Lomitapide—Increased appetite—Capecitabine—colon cancer	0.000631	0.00516	CcSEcCtD
Lomitapide—Urinary tract disorder—Vincristine—colon cancer	0.000621	0.00508	CcSEcCtD
Lomitapide—Dermatitis bullous—Capecitabine—colon cancer	0.00062	0.00507	CcSEcCtD
Lomitapide—Connective tissue disorder—Vincristine—colon cancer	0.000618	0.00505	CcSEcCtD
Lomitapide—Urethral disorder—Vincristine—colon cancer	0.000616	0.00504	CcSEcCtD
Lomitapide—Sinusitis—Fluorouracil—colon cancer	0.000613	0.00501	CcSEcCtD
Lomitapide—Connective tissue disorder—Irinotecan—colon cancer	0.000602	0.00492	CcSEcCtD
Lomitapide—Pain in extremity—Capecitabine—colon cancer	0.000593	0.00484	CcSEcCtD
Lomitapide—ABCB1—bone marrow—colon cancer	0.000588	0.00935	CbGeAlD
Lomitapide—Cardiac disorder—Vincristine—colon cancer	0.000584	0.00477	CcSEcCtD
Lomitapide—Migraine—Capecitabine—colon cancer	0.000583	0.00477	CcSEcCtD
Lomitapide—Cardiac disorder—Irinotecan—colon cancer	0.000568	0.00465	CcSEcCtD
Lomitapide—Mediastinal disorder—Vincristine—colon cancer	0.000567	0.00463	CcSEcCtD
Lomitapide—ABCB1—vagina—colon cancer	0.000563	0.00896	CbGeAlD
Lomitapide—Mediastinal disorder—Irinotecan—colon cancer	0.000552	0.00451	CcSEcCtD
Lomitapide—Dehydration—Capecitabine—colon cancer	0.000551	0.00451	CcSEcCtD
Lomitapide—Chills—Irinotecan—colon cancer	0.00055	0.00449	CcSEcCtD
Lomitapide—Ecchymosis—Methotrexate—colon cancer	0.000549	0.00449	CcSEcCtD
Lomitapide—Liver function test abnormal—Capecitabine—colon cancer	0.000547	0.00447	CcSEcCtD
Lomitapide—Dry skin—Capecitabine—colon cancer	0.000543	0.00444	CcSEcCtD
Lomitapide—Abdominal pain upper—Capecitabine—colon cancer	0.000541	0.00442	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000534	0.00436	CcSEcCtD
Lomitapide—Nasopharyngitis—Capecitabine—colon cancer	0.00053	0.00433	CcSEcCtD
Lomitapide—Back pain—Vincristine—colon cancer	0.00053	0.00433	CcSEcCtD
Lomitapide—Flatulence—Irinotecan—colon cancer	0.000525	0.0043	CcSEcCtD
Lomitapide—Gastritis—Capecitabine—colon cancer	0.000524	0.00429	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000523	0.00427	CcSEcCtD
Lomitapide—Back pain—Irinotecan—colon cancer	0.000516	0.00422	CcSEcCtD
Lomitapide—Abdominal distension—Capecitabine—colon cancer	0.000516	0.00422	CcSEcCtD
Lomitapide—Muscle spasms—Irinotecan—colon cancer	0.000513	0.00419	CcSEcCtD
Lomitapide—Influenza—Capecitabine—colon cancer	0.000512	0.00419	CcSEcCtD
Lomitapide—Anaemia—Vincristine—colon cancer	0.000506	0.00414	CcSEcCtD
Lomitapide—Angina pectoris—Capecitabine—colon cancer	0.000499	0.00408	CcSEcCtD
Lomitapide—Ill-defined disorder—Irinotecan—colon cancer	0.000495	0.00404	CcSEcCtD
Lomitapide—Anaemia—Irinotecan—colon cancer	0.000493	0.00403	CcSEcCtD
Lomitapide—Vertigo—Vincristine—colon cancer	0.000492	0.00402	CcSEcCtD
Lomitapide—Abdominal discomfort—Capecitabine—colon cancer	0.000491	0.00401	CcSEcCtD
Lomitapide—Malaise—Irinotecan—colon cancer	0.000481	0.00393	CcSEcCtD
Lomitapide—Vertigo—Irinotecan—colon cancer	0.000479	0.00392	CcSEcCtD
Lomitapide—ABCB1—liver—colon cancer	0.000475	0.00756	CbGeAlD
Lomitapide—Anaemia—Fluorouracil—colon cancer	0.000472	0.00386	CcSEcCtD
Lomitapide—Myalgia—Vincristine—colon cancer	0.000466	0.00381	CcSEcCtD
Lomitapide—Weight decreased—Capecitabine—colon cancer	0.000463	0.00379	CcSEcCtD
Lomitapide—Infestation NOS—Capecitabine—colon cancer	0.000457	0.00373	CcSEcCtD
Lomitapide—Infestation—Capecitabine—colon cancer	0.000457	0.00373	CcSEcCtD
Lomitapide—Discomfort—Irinotecan—colon cancer	0.000448	0.00367	CcSEcCtD
Lomitapide—Infection—Vincristine—colon cancer	0.000444	0.00363	CcSEcCtD
Lomitapide—Nervous system disorder—Vincristine—colon cancer	0.000438	0.00358	CcSEcCtD
Lomitapide—Haematuria—Capecitabine—colon cancer	0.000435	0.00356	CcSEcCtD
Lomitapide—Myalgia—Fluorouracil—colon cancer	0.000435	0.00355	CcSEcCtD
Lomitapide—Chest pain—Fluorouracil—colon cancer	0.000435	0.00355	CcSEcCtD
Lomitapide—Infection—Irinotecan—colon cancer	0.000432	0.00353	CcSEcCtD
Lomitapide—Hyperhidrosis—Vincristine—colon cancer	0.000432	0.00353	CcSEcCtD
Lomitapide—Hepatobiliary disease—Capecitabine—colon cancer	0.000432	0.00353	CcSEcCtD
Lomitapide—Discomfort—Fluorouracil—colon cancer	0.00043	0.00351	CcSEcCtD
Lomitapide—Nervous system disorder—Irinotecan—colon cancer	0.000427	0.00349	CcSEcCtD
Lomitapide—Hyperhidrosis—Irinotecan—colon cancer	0.000421	0.00344	CcSEcCtD
Lomitapide—Infection—Fluorouracil—colon cancer	0.000414	0.00339	CcSEcCtD
Lomitapide—Nervous system disorder—Fluorouracil—colon cancer	0.000409	0.00334	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—colon cancer	0.000407	0.00333	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000407	0.00333	CcSEcCtD
Lomitapide—Urinary tract disorder—Capecitabine—colon cancer	0.000405	0.00331	CcSEcCtD
Lomitapide—Connective tissue disorder—Capecitabine—colon cancer	0.000403	0.00329	CcSEcCtD
Lomitapide—Urethral disorder—Capecitabine—colon cancer	0.000402	0.00329	CcSEcCtD
Lomitapide—Paraesthesia—Vincristine—colon cancer	0.000401	0.00328	CcSEcCtD
Lomitapide—Paraesthesia—Irinotecan—colon cancer	0.000391	0.00319	CcSEcCtD
Lomitapide—Decreased appetite—Vincristine—colon cancer	0.000388	0.00318	CcSEcCtD
Lomitapide—Somnolence—Irinotecan—colon cancer	0.000387	0.00316	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Vincristine—colon cancer	0.000386	0.00315	CcSEcCtD
Lomitapide—Fatigue—Vincristine—colon cancer	0.000385	0.00315	CcSEcCtD
Lomitapide—Eye disorder—Capecitabine—colon cancer	0.000383	0.00313	CcSEcCtD
Lomitapide—Dyspepsia—Irinotecan—colon cancer	0.000383	0.00313	CcSEcCtD
Lomitapide—Constipation—Vincristine—colon cancer	0.000382	0.00312	CcSEcCtD
Lomitapide—Cardiac disorder—Capecitabine—colon cancer	0.00038	0.00311	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00038	0.0031	CcSEcCtD
Lomitapide—Decreased appetite—Irinotecan—colon cancer	0.000378	0.00309	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000376	0.00307	CcSEcCtD
Lomitapide—Fatigue—Irinotecan—colon cancer	0.000375	0.00307	CcSEcCtD
Lomitapide—Paraesthesia—Fluorouracil—colon cancer	0.000374	0.00306	CcSEcCtD
Lomitapide—Constipation—Irinotecan—colon cancer	0.000372	0.00304	CcSEcCtD
Lomitapide—Somnolence—Fluorouracil—colon cancer	0.00037	0.00303	CcSEcCtD
Lomitapide—Mediastinal disorder—Capecitabine—colon cancer	0.000369	0.00302	CcSEcCtD
Lomitapide—Chills—Capecitabine—colon cancer	0.000368	0.00301	CcSEcCtD
Lomitapide—Dyspepsia—Fluorouracil—colon cancer	0.000367	0.003	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—colon cancer	0.000365	0.00299	CcSEcCtD
Lomitapide—Gastrointestinal pain—Vincristine—colon cancer	0.000365	0.00299	CcSEcCtD
Lomitapide—ABCB1—lymph node—colon cancer	0.000364	0.00579	CbGeAlD
Lomitapide—Decreased appetite—Fluorouracil—colon cancer	0.000362	0.00296	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00036	0.00294	CcSEcCtD
Lomitapide—Feeling abnormal—Irinotecan—colon cancer	0.000359	0.00293	CcSEcCtD
Lomitapide—Malnutrition—Capecitabine—colon cancer	0.000357	0.00292	CcSEcCtD
Lomitapide—Gastrointestinal pain—Irinotecan—colon cancer	0.000356	0.00291	CcSEcCtD
Lomitapide—Abdominal pain—Vincristine—colon cancer	0.000353	0.00289	CcSEcCtD
Lomitapide—Body temperature increased—Vincristine—colon cancer	0.000353	0.00289	CcSEcCtD
Lomitapide—Flatulence—Capecitabine—colon cancer	0.000352	0.00287	CcSEcCtD
Lomitapide—Back pain—Capecitabine—colon cancer	0.000345	0.00282	CcSEcCtD
Lomitapide—Abdominal pain—Irinotecan—colon cancer	0.000344	0.00281	CcSEcCtD
Lomitapide—Body temperature increased—Irinotecan—colon cancer	0.000344	0.00281	CcSEcCtD
Lomitapide—Feeling abnormal—Fluorouracil—colon cancer	0.000343	0.00281	CcSEcCtD
Lomitapide—Muscle spasms—Capecitabine—colon cancer	0.000343	0.00281	CcSEcCtD
Lomitapide—Infestation—Methotrexate—colon cancer	0.00034	0.00278	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—colon cancer	0.00034	0.00278	CcSEcCtD
Lomitapide—Ill-defined disorder—Capecitabine—colon cancer	0.000331	0.00271	CcSEcCtD
Lomitapide—Anaemia—Capecitabine—colon cancer	0.00033	0.0027	CcSEcCtD
Lomitapide—Body temperature increased—Fluorouracil—colon cancer	0.000329	0.00269	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—colon cancer	0.000324	0.00265	CcSEcCtD
Lomitapide—Malaise—Capecitabine—colon cancer	0.000322	0.00263	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—colon cancer	0.000321	0.00263	CcSEcCtD
Lomitapide—Vertigo—Capecitabine—colon cancer	0.000321	0.00262	CcSEcCtD
Lomitapide—Asthenia—Vincristine—colon cancer	0.000321	0.00262	CcSEcCtD
Lomitapide—Palpitations—Capecitabine—colon cancer	0.000315	0.00258	CcSEcCtD
Lomitapide—Asthenia—Irinotecan—colon cancer	0.000312	0.00255	CcSEcCtD
Lomitapide—Diarrhoea—Vincristine—colon cancer	0.000306	0.0025	CcSEcCtD
Lomitapide—Chest pain—Capecitabine—colon cancer	0.000304	0.00248	CcSEcCtD
Lomitapide—Myalgia—Capecitabine—colon cancer	0.000304	0.00248	CcSEcCtD
Lomitapide—Arthralgia—Capecitabine—colon cancer	0.000304	0.00248	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000302	0.00247	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—colon cancer	0.000301	0.00246	CcSEcCtD
Lomitapide—Discomfort—Capecitabine—colon cancer	0.0003	0.00245	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—colon cancer	0.000299	0.00245	CcSEcCtD
Lomitapide—Diarrhoea—Irinotecan—colon cancer	0.000298	0.00243	CcSEcCtD
Lomitapide—Dry mouth—Capecitabine—colon cancer	0.000297	0.00243	CcSEcCtD
Lomitapide—Dizziness—Vincristine—colon cancer	0.000295	0.00242	CcSEcCtD
Lomitapide—Infection—Capecitabine—colon cancer	0.000289	0.00237	CcSEcCtD
Lomitapide—Dizziness—Irinotecan—colon cancer	0.000288	0.00235	CcSEcCtD
Lomitapide—Nervous system disorder—Capecitabine—colon cancer	0.000286	0.00234	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—colon cancer	0.000285	0.00233	CcSEcCtD
Lomitapide—Diarrhoea—Fluorouracil—colon cancer	0.000285	0.00233	CcSEcCtD
Lomitapide—Vomiting—Vincristine—colon cancer	0.000284	0.00232	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—colon cancer	0.000283	0.00232	CcSEcCtD
Lomitapide—Skin disorder—Capecitabine—colon cancer	0.000283	0.00231	CcSEcCtD
Lomitapide—Hyperhidrosis—Capecitabine—colon cancer	0.000282	0.0023	CcSEcCtD
Lomitapide—Headache—Vincristine—colon cancer	0.00028	0.00229	CcSEcCtD
Lomitapide—Vomiting—Irinotecan—colon cancer	0.000277	0.00226	CcSEcCtD
Lomitapide—Dizziness—Fluorouracil—colon cancer	0.000276	0.00225	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—colon cancer	0.000275	0.00225	CcSEcCtD
Lomitapide—Chills—Methotrexate—colon cancer	0.000274	0.00224	CcSEcCtD
Lomitapide—Headache—Irinotecan—colon cancer	0.000273	0.00223	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—colon cancer	0.000266	0.00217	CcSEcCtD
Lomitapide—Nausea—Vincristine—colon cancer	0.000265	0.00217	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000265	0.00217	CcSEcCtD
Lomitapide—Vomiting—Fluorouracil—colon cancer	0.000265	0.00217	CcSEcCtD
Lomitapide—Paraesthesia—Capecitabine—colon cancer	0.000261	0.00214	CcSEcCtD
Lomitapide—Headache—Fluorouracil—colon cancer	0.000261	0.00213	CcSEcCtD
Lomitapide—Nausea—Irinotecan—colon cancer	0.000258	0.00211	CcSEcCtD
Lomitapide—Back pain—Methotrexate—colon cancer	0.000257	0.0021	CcSEcCtD
Lomitapide—Dyspepsia—Capecitabine—colon cancer	0.000256	0.0021	CcSEcCtD
Lomitapide—Decreased appetite—Capecitabine—colon cancer	0.000253	0.00207	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000251	0.00206	CcSEcCtD
Lomitapide—Fatigue—Capecitabine—colon cancer	0.000251	0.00205	CcSEcCtD
Lomitapide—Constipation—Capecitabine—colon cancer	0.000249	0.00204	CcSEcCtD
Lomitapide—Nausea—Fluorouracil—colon cancer	0.000248	0.00202	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—colon cancer	0.000246	0.00202	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—colon cancer	0.000246	0.00201	CcSEcCtD
Lomitapide—Feeling abnormal—Capecitabine—colon cancer	0.00024	0.00196	CcSEcCtD
Lomitapide—Malaise—Methotrexate—colon cancer	0.00024	0.00196	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—colon cancer	0.000239	0.00195	CcSEcCtD
Lomitapide—Gastrointestinal pain—Capecitabine—colon cancer	0.000238	0.00195	CcSEcCtD
Lomitapide—Abdominal pain—Capecitabine—colon cancer	0.00023	0.00188	CcSEcCtD
Lomitapide—Body temperature increased—Capecitabine—colon cancer	0.00023	0.00188	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—colon cancer	0.000226	0.00185	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—colon cancer	0.000226	0.00185	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—colon cancer	0.000226	0.00185	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000225	0.00184	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—colon cancer	0.000223	0.00183	CcSEcCtD
Lomitapide—Infection—Methotrexate—colon cancer	0.000215	0.00176	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—colon cancer	0.000213	0.00174	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—colon cancer	0.000211	0.00172	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—colon cancer	0.00021	0.00171	CcSEcCtD
Lomitapide—Asthenia—Capecitabine—colon cancer	0.000209	0.00171	CcSEcCtD
Lomitapide—Diarrhoea—Capecitabine—colon cancer	0.000199	0.00163	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000198	0.00161	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—colon cancer	0.000195	0.00159	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—colon cancer	0.000193	0.00158	CcSEcCtD
Lomitapide—Dizziness—Capecitabine—colon cancer	0.000193	0.00157	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—colon cancer	0.000191	0.00156	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—colon cancer	0.000188	0.00154	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000187	0.00153	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—colon cancer	0.000187	0.00153	CcSEcCtD
Lomitapide—Vomiting—Capecitabine—colon cancer	0.000185	0.00151	CcSEcCtD
Lomitapide—Headache—Capecitabine—colon cancer	0.000182	0.00149	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—colon cancer	0.000179	0.00146	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—colon cancer	0.000177	0.00145	CcSEcCtD
Lomitapide—Nausea—Capecitabine—colon cancer	0.000173	0.00141	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—colon cancer	0.000171	0.0014	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—colon cancer	0.000171	0.0014	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—colon cancer	0.000156	0.00127	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—colon cancer	0.000148	0.00121	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—colon cancer	0.000143	0.00117	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—colon cancer	0.000138	0.00113	CcSEcCtD
Lomitapide—Headache—Methotrexate—colon cancer	0.000136	0.00111	CcSEcCtD
Lomitapide—Nausea—Methotrexate—colon cancer	0.000129	0.00105	CcSEcCtD
